Skip to main content

Pfizer Inc.

corporate_fare Company Profile

Pfizer Inc.

PFE·NYSE·Life Sciences·CIK 0000078003

Pfizer Inc. is a research-based, global biopharmaceutical company that discovers, develops, manufactures, markets, sells, and distributes biopharmaceutical products worldwide. The company applies science and global resources to provide therapies that extend and significantly improve lives. Pfizer operates in both developed and emerging markets, focusing on wellness, prevention, treatments, and cures for significant diseases. It collaborates with healthcare providers, governments, and local communities to support and expand access to reliable, affordable healthcare globally. Incorporated in Delaware on June 2, 1942, Pfizer generates most of its revenues from the manufacture and sale of biopharmaceutical products. The company aims to enhance the value of its medicines and vaccines and works with patients, physicians, and payors to prevent and treat disease and improve outcomes. Pfizer evaluates its pricing arrangements and contracting methods with payors to maximize patient access while minimizing adverse impacts on revenues within current legal and pricing structures.

Pfizer Inc. (NYSE:PFE) is a publicly traded company in the Life Sciences sector. Wiseek monitors PFE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Pfizer Beats Q2 Estimates, Raises Revenue Outlook, and Touts Obesity Drug Data
  • Pfizer Boosts Cost-Savings Target to $6.7B, Sets 2028 Berobenatide Approval Goal
  • Pfizer Beats Q2 Estimates but Guidance Midpoint Disappoints, Stock Falls
  • Pfizer Swings to Q2 Loss on $4.3B Impairment; Expands Cost Cuts, Secures Tariff Relief
  • Pfizer Reports Q2 Results, Raises Revenue Guidance, But Takes $4.3B Impairment Charge

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$62.58B
Net Income
$7.77B
Diluted EPS
$1.36
Op. Cash Flow
$11.7B
Free Cash Flow
$9.07B
Gross Profit
$46.51B
Cash & Equivalents
$1.14B
Total Debt
$64.64B
Debt / Equity
0.75×
Net Margin
12.4%
Shares Outstanding
5.68B sh
Source: 10-K · filed 2026-02-26 · accession 0000078003-26-000026
Browse all tickers starting with P →
$26.67 -0.09% today
52-week range · as of 2026-08-04 $23.11 – $28.75
Market cap
$152.52B
Volume
42.7M (1.0× avg)
3-mo avg 43.4M
Live data · 2026-08-08 03:43 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed PFE - Latest Insights

PFE
Aug 04, 2026, 12:49 PM EDT
Source: Benzinga
Importance Score:
9
Price at Filing: $25.45
Real-time Price: $26.67 info
Change: +$1.23 (+5%) info
Market Cap: $152.523B info
PFE
Aug 04, 2026, 10:30 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $24.89
Real-time Price: $26.67 info
Change: +$1.79 (+7%) info
Market Cap: $152.523B info
PFE
Aug 04, 2026, 7:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $25.07
Real-time Price: $26.67 info
Change: +$1.60 (+6%) info
Market Cap: $152.523B info
PFE
Aug 04, 2026, 7:04 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $25.11
Real-time Price: $26.67 info
Change: +$1.56 (+6%) info
Market Cap: $152.523B info
PFE
Aug 04, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.94
Real-time Price: $26.67 info
Change: +$1.73 (+7%) info
Market Cap: $152.523B info
PFE
Jul 30, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $25.04
Real-time Price: $26.67 info
Change: +$1.63 (+7%) info
Market Cap: $152.523B info
PFE
Jul 22, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $24.88
Real-time Price: $26.67 info
Change: +$1.79 (+7%) info
Market Cap: $152.523B info
PFE
Jul 10, 2026, 11:24 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $24.24
Real-time Price: $26.67 info
Change: +$2.44 (+10%) info
Market Cap: $152.523B info
PFE
Jul 10, 2026, 8:22 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $24.31
Real-time Price: $26.67 info
Change: +$2.36 (+10%) info
Market Cap: $152.523B info
PFE
Jul 07, 2026, 3:22 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $24.04
Real-time Price: $26.67 info
Change: +$2.63 (+11%) info
Market Cap: $152.523B info
PFE
Jun 25, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $24.10
Real-time Price: $26.67 info
Change: +$2.57 (+11%) info
Market Cap: $152.523B info
PFE
Jun 24, 2026, 11:48 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $24.25
Real-time Price: $26.67 info
Change: +$2.43 (+10%) info
Market Cap: $152.523B info
PFE
Jun 24, 2026, 10:48 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $24.52
Real-time Price: $26.67 info
Change: +$2.15 (+9%) info
Market Cap: $152.523B info
PFE
Jun 24, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $24.74
Real-time Price: $26.67 info
Change: +$1.93 (+8%) info
Market Cap: $152.523B info
PFE
Jun 22, 2026, 4:54 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $24.65
Real-time Price: $26.67 info
Change: +$2.02 (+8%) info
Market Cap: $152.523B info
PFE
Jun 19, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $25.25
Real-time Price: $26.67 info
Change: +$1.42 (+6%) info
Market Cap: $152.523B info
PFE
Jun 18, 2026, 7:22 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $25.49
Real-time Price: $26.67 info
Change: +$1.18 (+5%) info
Market Cap: $152.523B info
PFE
Jun 18, 2026, 7:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.49
Real-time Price: $26.67 info
Change: +$1.18 (+5%) info
Market Cap: $152.523B info
PFE
Jun 17, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $26.04
Real-time Price: $26.67 info
Change: +$0.630 (+2%) info
Market Cap: $152.523B info
PFE
Jun 15, 2026, 12:51 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $26.21
Real-time Price: $26.67 info
Change: +$0.4626 (+2%) info
Market Cap: $152.523B info